APO Research, Inc.

APO RESEARCH · REPORT

Pathology Imaging Systems

Selected research

Market Analysis & Forecast

Global Pathology Imaging Systems Market Analysis and Forecast 2026-2032

Market perspective

The global Pathology Imaging Systems market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pathology Imaging Systems is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pathology Imaging Systems is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pathology Imaging Systems is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pathology Imaging Systems is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pathology Imaging Systems include Winning Health Technology Group Co.,Ltd., Beijing Wandong Medical Technology Co.,Ltd., Hangzhou Century Co.,Ltd, Imsight, Micro-tech (nanjing) Co.,ltd., Motic (Xiamen)Electric, Landing Med, Huayin Medical Laboratory and Neusoft Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pathology Imaging Systems, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pathology Imaging Systems, also provides the revenue of main regions and countries. Of the upcoming market potential for Pathology Imaging Systems, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pathology Imaging Systems revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pathology Imaging Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pathology Imaging Systems revenue, projected growth trends, production technology, application and end-user industry.

Pathology Imaging Systems Segment by Company

Winning Health Technology Group Co.,Ltd.

Beijing Wandong Medical Technology Co.,Ltd.

Hangzhou Century Co.,Ltd

Imsight

Micro-tech (nanjing) Co.,ltd.

Motic (Xiamen)Electric

Landing Med

Huayin Medical Laboratory

Neusoft Group

Siemens

Sakura Finetek

Philips Healthcare

Perkin Elmer

Olympus Corporation

Leica Biosystems

Hamamatsu Photonics

GE Healthcare

DigiPath

Carl Zeiss Meditec

3D-Histech

Pathology Imaging Systems Segment by Type

Imaging Systems

Accessories and Software Services

Pathology Imaging Systems Segment by Application

Hospitals

Clinics

Others

Pathology Imaging Systems Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pathology Imaging Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pathology Imaging Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pathology Imaging Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pathology Imaging Systems in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pathology Imaging Systems company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pathology Imaging Systems revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pathology Imaging Systems Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Imaging Systems Major Player Table 3. Accessories and Software Services Major Player Table 4. Global Pathology Imaging Systems Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Player Table 6. Clinics Major Player Table 7. Others Major Player Table 8. Pathology Imaging Systems Industry Trends Table 9. Pathology Imaging Systems Industry Drivers Table 10. Pathology Imaging Systems Industry Opportunities and Challenges Table 11. Pathology Imaging Systems Industry Restraints Table 12. Global Pathology Imaging Systems Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Pathology Imaging Systems Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Pathology Imaging Systems Market Share by Region (2021-2026) Table 15. Global Pathology Imaging Systems Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Pathology Imaging Systems Market Share by Region (2027-2032) Table 17. Global Pathology Imaging Systems Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Pathology Imaging Systems Revenue Market Share by Players (2021-2026) Table 19. Global Pathology Imaging Systems Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pathology Imaging Systems Key Players Headquarters & Area Served Table 21. Global Pathology Imaging Systems Players, Product Type & Application Table 22. Global Pathology Imaging Systems Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Pathology Imaging Systems by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Pathology Imaging Systems Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pathology Imaging Systems Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Pathology Imaging Systems Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Pathology Imaging Systems Revenue Market Share by Type (2021-2026) Table 29. Global Pathology Imaging Systems Revenue Market Share by Type (2027-2032) Table 30. Global Pathology Imaging Systems Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pathology Imaging Systems Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Pathology Imaging Systems Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Pathology Imaging Systems Revenue Market Share by Application (2021-2026) Table 34. Global Pathology Imaging Systems Revenue Market Share by Application (2027-2032) Table 35. Winning Health Technology Group Co.,Ltd. Company Information Table 36. Winning Health Technology Group Co.,Ltd. Business Overview Table 37. Winning Health Technology Group Co.,Ltd. Pathology Imaging Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Winning Health Technology Group Co.,Ltd. Pathology Imaging Systems Product Portfolio Table 39. Winning Health Technology Group Co.,Ltd. Recent Development Table 40. Beijing Wandong Medical Technology Co.,Ltd. Company Information Table 41. Beijing Wandong Medical Technology Co.,Ltd. Business Overview Table 42. Beijing Wandong Medical Technology Co.,Ltd. Pathology Imaging Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Beijing Wandong Medical Technology Co.,Ltd. Pathology Imaging Systems Product Portfolio Table 44. Beijing Wandong Medical Technology Co.,Ltd. Recent Development Table 45. Hangzhou Century Co.,Ltd Company Information Table 46. Hangzhou Century Co.,Ltd Business Overview Table 47. Hangzhou Century Co.,Ltd Pathology Imaging Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Hangzhou Century Co.,Ltd Pathology Imaging Systems Product Portfolio Table 49. Hangzhou Century Co.,Ltd Recent Development Table 50. Imsight Company Information Table 51. Imsight Business Overview Table 52. Imsight Pathology Imaging Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Imsight Pathology Imaging Systems Product Portfolio Table 54. Imsight Recent Development Table 55. Micro-tech (nanjing) Co.,ltd. Company Information Table 56. Micro-tech (nanjing) Co.,ltd. Business Overview Table 57. Micro-tech (nanjing) Co.,ltd. Pathology Imaging Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Micro-tech (nanjing) Co.,ltd. Pathology Imaging Systems Product Portfolio Table 59. Micro-tech (nanjing) Co.,ltd. Recent Development Table 60. Motic (Xiamen)Electric Company Information Table 61. Motic (Xiamen)Electric Business Overview Table 62. Motic (Xiamen)Electric Pathology Imaging Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Motic (Xiamen)Electric Pathology Imaging Systems Product Portfolio Table 64. Motic (Xiamen)Electric Recent Development Table 65. Landing Med Company Information Table 66. Landing Med Business Overview Table 67. Landing Med Pathology Imaging Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Landing Med Pathology Imaging Systems Product Portfolio Table 69. Landing Med Recent Development Table 70. Huayin Medical Laboratory Company Information Table 71. Huayin Medical Laboratory Business Overview Table 72. Huayin Medical Laboratory Pathology Imaging Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Huayin Medical Laboratory Pathology Imaging Systems Product Portfolio Table 74. Huayin Medical Laboratory Recent Development Table 75. Neusoft Group Company Information Table 76. Neusoft Group Business Overview Table 77. Neusoft Group Pathology Imaging Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Neusoft Group Pathology Imaging Systems Product Portfolio Table 79. Neusoft Group Recent Development Table 80. Siemens Company Information Table 81. Siemens Business Overview Table 82. Siemens Pathology Imaging Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Siemens Pathology Imaging Systems Product Portfolio Table 84. Siemens Recent Development Table 85. Sakura Finetek Company Information Table 86. Sakura Finetek Business Overview Table 87. Sakura Finetek Pathology Imaging Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Sakura Finetek Pathology Imaging Systems Product Portfolio Table 89. Sakura Finetek Recent Development Table 90. Philips Healthcare Company Information Table 91. Philips Healthcare Business Overview Table 92. Philips Healthcare Pathology Imaging Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Philips Healthcare Pathology Imaging Systems Product Portfolio Table 94. Philips Healthcare Recent Development Table 95. Perkin Elmer Company Information Table 96. Perkin Elmer Business Overview Table 97. Perkin Elmer Pathology Imaging Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Perkin Elmer Pathology Imaging Systems Product Portfolio Table 99. Perkin Elmer Recent Development Table 100. Olympus Corporation Company Information Table 101. Olympus Corporation Business Overview Table 102. Olympus Corporation Pathology Imaging Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Olympus Corporation Pathology Imaging Systems Product Portfolio Table 104. Olympus Corporation Recent Development Table 105. Leica Biosystems Company Information Table 106. Leica Biosystems Business Overview Table 107. Leica Biosystems Pathology Imaging Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Leica Biosystems Pathology Imaging Systems Product Portfolio Table 109. Leica Biosystems Recent Development Table 110. Hamamatsu Photonics Company Information Table 111. Hamamatsu Photonics Business Overview Table 112. Hamamatsu Photonics Pathology Imaging Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Hamamatsu Photonics Pathology Imaging Systems Product Portfolio Table 114. Hamamatsu Photonics Recent Development Table 115. GE Healthcare Company Information Table 116. GE Healthcare Business Overview Table 117. GE Healthcare Pathology Imaging Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. GE Healthcare Pathology Imaging Systems Product Portfolio Table 119. GE Healthcare Recent Development Table 120. DigiPath Company Information Table 121. DigiPath Business Overview Table 122. DigiPath Pathology Imaging Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. DigiPath Pathology Imaging Systems Product Portfolio Table 124. DigiPath Recent Development Table 125. Carl Zeiss Meditec Company Information Table 126. Carl Zeiss Meditec Business Overview Table 127. Carl Zeiss Meditec Pathology Imaging Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Carl Zeiss Meditec Pathology Imaging Systems Product Portfolio Table 129. Carl Zeiss Meditec Recent Development Table 130. 3D-Histech Company Information Table 131. 3D-Histech Business Overview Table 132. 3D-Histech Pathology Imaging Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. 3D-Histech Pathology Imaging Systems Product Portfolio Table 134. 3D-Histech Recent Development Table 135. North America Pathology Imaging Systems Revenue by Type (2021-2026) & (US$ Million) Table 136. North America Pathology Imaging Systems Revenue by Type (2027-2032) & (US$ Million) Table 137. North America Pathology Imaging Systems Revenue by Application (2021-2026) & (US$ Million) Table 138. North America Pathology Imaging Systems Revenue by Application (2027-2032) & (US$ Million) Table 139. North America Pathology Imaging Systems Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. North America Pathology Imaging Systems Revenue by Country (2021-2026) & (US$ Million) Table 141. North America Pathology Imaging Systems Revenue by Country (US$ Million) & (2027-2032) Table 142. Europe Pathology Imaging Systems Revenue by Type (2021-2026) & (US$ Million) Table 143. Europe Pathology Imaging Systems Revenue by Type (2027-2032) & (US$ Million) Table 144. Europe Pathology Imaging Systems Revenue by Application (2021-2026) & (US$ Million) Table 145. Europe Pathology Imaging Systems Revenue by Application (2027-2032) & (US$ Million) Table 146. Europe Pathology Imaging Systems Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Pathology Imaging Systems Revenue by Country (2021-2026) & (US$ Million) Table 148. Europe Pathology Imaging Systems Revenue by Country (US$ Million) & (2027-2032) Table 149. China Pathology Imaging Systems Revenue by Type (2021-2026) & (US$ Million) Table 150. China Pathology Imaging Systems Revenue by Type (2027-2032) & (US$ Million) Table 151. China Pathology Imaging Systems Revenue by Application (2021-2026) & (US$ Million) Table 152. China Pathology Imaging Systems Revenue by Application (2027-2032) & (US$ Million) Table 153. Asia Pathology Imaging Systems Revenue by Type (2021-2026) & (US$ Million) Table 154. Asia Pathology Imaging Systems Revenue by Type (2027-2032) & (US$ Million) Table 155. Asia Pathology Imaging Systems Revenue by Application (2021-2026) & (US$ Million) Table 156. Asia Pathology Imaging Systems Revenue by Application (2027-2032) & (US$ Million) Table 157. Asia Pathology Imaging Systems Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Asia Pathology Imaging Systems Revenue by Region (US$ Million) & (2021-2026) Table 159. Asia Pathology Imaging Systems Revenue by Region (US$ Million) & (2027-2032) Table 160. SAMEA Pathology Imaging Systems Revenue by Type (2021-2026) & (US$ Million) Table 161. SAMEA Pathology Imaging Systems Revenue by Type (2027-2032) & (US$ Million) Table 162. SAMEA Pathology Imaging Systems Revenue by Application (2021-2026) & (US$ Million) Table 163. SAMEA Pathology Imaging Systems Revenue by Application (2027-2032) & (US$ Million) Table 164. SAMEA Pathology Imaging Systems Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. SAMEA Pathology Imaging Systems Revenue by Country (2021-2026) & (US$ Million) Table 166. SAMEA Pathology Imaging Systems Revenue by Country (US$ Million) & (2027-2032) Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Pathology Imaging Systems Image Figure 2. Global Pathology Imaging Systems Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pathology Imaging Systems Market Size Share 2021 VS 2025 VS 2032 Figure 4. Imaging Systems Image Figure 5. Accessories and Software Services Image Figure 6. Global Pathology Imaging Systems Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pathology Imaging Systems Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Clinics Image Figure 10. Others Image Figure 11. Global Pathology Imaging Systems Market Size (US$ Million) & (2021-2032) Figure 12. Global Pathology Imaging Systems Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pathology Imaging Systems Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Pathology Imaging Systems Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Pathology Imaging Systems Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pathology Imaging Systems Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Pathology Imaging Systems Revenue Market Share by Type (2021-2032) Figure 19. Global Pathology Imaging Systems Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Pathology Imaging Systems Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Pathology Imaging Systems Revenue Market Share by Application (2021-2032) Figure 22. North America Pathology Imaging Systems Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Pathology Imaging Systems Revenue Share by Type (2021-2032) Figure 24. North America Pathology Imaging Systems Revenue Share by Application (2021-2032) Figure 25. North America Pathology Imaging Systems Revenue Share by Country (2021-2032) Figure 26. United States Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Pathology Imaging Systems Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Pathology Imaging Systems Revenue Share by Type (2021-2032) Figure 31. Europe Pathology Imaging Systems Revenue Share by Application (2021-2032) Figure 32. Europe Pathology Imaging Systems Revenue Share by Country (2021-2032) Figure 33. Germany Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Pathology Imaging Systems Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Pathology Imaging Systems Revenue Share by Type (2021-2032) Figure 43. China Pathology Imaging Systems Revenue Share by Application (2021-2032) Figure 44. Asia Pathology Imaging Systems Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Pathology Imaging Systems Revenue Share by Type (2021-2032) Figure 46. Asia Pathology Imaging Systems Revenue Share by Application (2021-2032) Figure 47. Asia Pathology Imaging Systems Revenue Share by Region (2021-2032) Figure 48. Japan Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Pathology Imaging Systems Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Pathology Imaging Systems Revenue Share by Type (2021-2032) Figure 56. SAMEA Pathology Imaging Systems Revenue Share by Application (2021-2032) Figure 57. SAMEA Pathology Imaging Systems Revenue Share by Country (2021-2032) Figure 58. Brazil Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Pathology Imaging Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Imaging Systems
  • Accessories and Software Services
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Winning Health Technology Group Co.,Ltd.
  • Beijing Wandong Medical Technology Co.,Ltd.
  • Hangzhou Century Co.,Ltd
  • Imsight
  • Micro-tech (nanjing) Co.,ltd.
  • Motic (Xiamen)Electric
  • Landing Med
  • Huayin Medical Laboratory
  • Neusoft Group
  • Siemens
  • Sakura Finetek
  • Philips Healthcare
  • Perkin Elmer
  • Olympus Corporation
  • Leica Biosystems
  • Hamamatsu Photonics
  • GE Healthcare
  • DigiPath
  • Carl Zeiss Meditec
  • 3D-Histech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pathology Imaging Systems Market by Type
  3. 1.2.1 Global Pathology Imaging Systems Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Imaging Systems
  5. 1.2.3 Accessories and Software Services
  6. 1.3 Pathology Imaging Systems Market by Application
  7. 1.3.1 Global Pathology Imaging Systems Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Clinics
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Pathology Imaging Systems Market Dynamics
  1. 2.1 Pathology Imaging Systems Industry Trends
  2. 2.2 Pathology Imaging Systems Industry Drivers
  3. 2.3 Pathology Imaging Systems Industry Opportunities and Challenges
  4. 2.4 Pathology Imaging Systems Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pathology Imaging Systems Market Perspective (2021-2032)
  2. 3.2 Global Pathology Imaging Systems Growth Trends by Region
  3. 3.2.1 Global Pathology Imaging Systems Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pathology Imaging Systems Market Size by Region (2021-2026)
  5. 3.2.3 Global Pathology Imaging Systems Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pathology Imaging Systems Revenue by Players
  2. 4.1.1 Global Pathology Imaging Systems Revenue by Players (2021-2026)
  3. 4.1.2 Global Pathology Imaging Systems Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pathology Imaging Systems Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pathology Imaging Systems Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pathology Imaging Systems Key Players Headquarters & Area Served
  7. 4.4 Global Pathology Imaging Systems Players, Product Type & Application
  8. 4.5 Global Pathology Imaging Systems Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pathology Imaging Systems Market CR5 and HHI
  11. 4.6.3 2025 Pathology Imaging Systems Tier 1, Tier 2, and Tier 3
5 Pathology Imaging Systems Market Size by Type
  1. 5.1 Global Pathology Imaging Systems Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pathology Imaging Systems Revenue by Type (2021-2032)
  3. 5.3 Global Pathology Imaging Systems Revenue Market Share by Type (2021-2032)
6 Pathology Imaging Systems Market Size by Application
  1. 6.1 Global Pathology Imaging Systems Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pathology Imaging Systems Revenue by Application (2021-2032)
  3. 6.3 Global Pathology Imaging Systems Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Winning Health Technology Group Co.,Ltd.
  2. 7.1.1 Winning Health Technology Group Co.,Ltd. Company Information
  3. 7.1.2 Winning Health Technology Group Co.,Ltd. Business Overview
  4. 7.1.3 Winning Health Technology Group Co.,Ltd. Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Winning Health Technology Group Co.,Ltd. Pathology Imaging Systems Product Portfolio
  6. 7.1.5 Winning Health Technology Group Co.,Ltd. Recent Developments
  7. 7.2 Beijing Wandong Medical Technology Co.,Ltd.
  8. 7.2.1 Beijing Wandong Medical Technology Co.,Ltd. Company Information
  9. 7.2.2 Beijing Wandong Medical Technology Co.,Ltd. Business Overview
  10. 7.2.3 Beijing Wandong Medical Technology Co.,Ltd. Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Beijing Wandong Medical Technology Co.,Ltd. Pathology Imaging Systems Product Portfolio
  12. 7.2.5 Beijing Wandong Medical Technology Co.,Ltd. Recent Developments
  13. 7.3 Hangzhou Century Co.,Ltd
  14. 7.3.1 Hangzhou Century Co.,Ltd Company Information
  15. 7.3.2 Hangzhou Century Co.,Ltd Business Overview
  16. 7.3.3 Hangzhou Century Co.,Ltd Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Hangzhou Century Co.,Ltd Pathology Imaging Systems Product Portfolio
  18. 7.3.5 Hangzhou Century Co.,Ltd Recent Developments
  19. 7.4 Imsight
  20. 7.4.1 Imsight Company Information
  21. 7.4.2 Imsight Business Overview
  22. 7.4.3 Imsight Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Imsight Pathology Imaging Systems Product Portfolio
  24. 7.4.5 Imsight Recent Developments
  25. 7.5 Micro-tech (nanjing) Co.,ltd.
  26. 7.5.1 Micro-tech (nanjing) Co.,ltd. Company Information
  27. 7.5.2 Micro-tech (nanjing) Co.,ltd. Business Overview
  28. 7.5.3 Micro-tech (nanjing) Co.,ltd. Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Micro-tech (nanjing) Co.,ltd. Pathology Imaging Systems Product Portfolio
  30. 7.5.5 Micro-tech (nanjing) Co.,ltd. Recent Developments
  31. 7.6 Motic (Xiamen)Electric
  32. 7.6.1 Motic (Xiamen)Electric Company Information
  33. 7.6.2 Motic (Xiamen)Electric Business Overview
  34. 7.6.3 Motic (Xiamen)Electric Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Motic (Xiamen)Electric Pathology Imaging Systems Product Portfolio
  36. 7.6.5 Motic (Xiamen)Electric Recent Developments
  37. 7.7 Landing Med
  38. 7.7.1 Landing Med Company Information
  39. 7.7.2 Landing Med Business Overview
  40. 7.7.3 Landing Med Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Landing Med Pathology Imaging Systems Product Portfolio
  42. 7.7.5 Landing Med Recent Developments
  43. 7.8 Huayin Medical Laboratory
  44. 7.8.1 Huayin Medical Laboratory Company Information
  45. 7.8.2 Huayin Medical Laboratory Business Overview
  46. 7.8.3 Huayin Medical Laboratory Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Huayin Medical Laboratory Pathology Imaging Systems Product Portfolio
  48. 7.8.5 Huayin Medical Laboratory Recent Developments
  49. 7.9 Neusoft Group
  50. 7.9.1 Neusoft Group Company Information
  51. 7.9.2 Neusoft Group Business Overview
  52. 7.9.3 Neusoft Group Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Neusoft Group Pathology Imaging Systems Product Portfolio
  54. 7.9.5 Neusoft Group Recent Developments
  55. 7.10 Siemens
  56. 7.10.1 Siemens Company Information
  57. 7.10.2 Siemens Business Overview
  58. 7.10.3 Siemens Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Siemens Pathology Imaging Systems Product Portfolio
  60. 7.10.5 Siemens Recent Developments
  61. 7.11 Sakura Finetek
  62. 7.11.1 Sakura Finetek Company Information
  63. 7.11.2 Sakura Finetek Business Overview
  64. 7.11.3 Sakura Finetek Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Sakura Finetek Pathology Imaging Systems Product Portfolio
  66. 7.11.5 Sakura Finetek Recent Developments
  67. 7.12 Philips Healthcare
  68. 7.12.1 Philips Healthcare Company Information
  69. 7.12.2 Philips Healthcare Business Overview
  70. 7.12.3 Philips Healthcare Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Philips Healthcare Pathology Imaging Systems Product Portfolio
  72. 7.12.5 Philips Healthcare Recent Developments
  73. 7.13 Perkin Elmer
  74. 7.13.1 Perkin Elmer Company Information
  75. 7.13.2 Perkin Elmer Business Overview
  76. 7.13.3 Perkin Elmer Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Perkin Elmer Pathology Imaging Systems Product Portfolio
  78. 7.13.5 Perkin Elmer Recent Developments
  79. 7.14 Olympus Corporation
  80. 7.14.1 Olympus Corporation Company Information
  81. 7.14.2 Olympus Corporation Business Overview
  82. 7.14.3 Olympus Corporation Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Olympus Corporation Pathology Imaging Systems Product Portfolio
  84. 7.14.5 Olympus Corporation Recent Developments
  85. 7.15 Leica Biosystems
  86. 7.15.1 Leica Biosystems Company Information
  87. 7.15.2 Leica Biosystems Business Overview
  88. 7.15.3 Leica Biosystems Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Leica Biosystems Pathology Imaging Systems Product Portfolio
  90. 7.15.5 Leica Biosystems Recent Developments
  91. 7.16 Hamamatsu Photonics
  92. 7.16.1 Hamamatsu Photonics Company Information
  93. 7.16.2 Hamamatsu Photonics Business Overview
  94. 7.16.3 Hamamatsu Photonics Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Hamamatsu Photonics Pathology Imaging Systems Product Portfolio
  96. 7.16.5 Hamamatsu Photonics Recent Developments
  97. 7.17 GE Healthcare
  98. 7.17.1 GE Healthcare Company Information
  99. 7.17.2 GE Healthcare Business Overview
  100. 7.17.3 GE Healthcare Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
  101. 7.17.4 GE Healthcare Pathology Imaging Systems Product Portfolio
  102. 7.17.5 GE Healthcare Recent Developments
  103. 7.18 DigiPath
  104. 7.18.1 DigiPath Company Information
  105. 7.18.2 DigiPath Business Overview
  106. 7.18.3 DigiPath Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
  107. 7.18.4 DigiPath Pathology Imaging Systems Product Portfolio
  108. 7.18.5 DigiPath Recent Developments
  109. 7.19 Carl Zeiss Meditec
  110. 7.19.1 Carl Zeiss Meditec Company Information
  111. 7.19.2 Carl Zeiss Meditec Business Overview
  112. 7.19.3 Carl Zeiss Meditec Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Carl Zeiss Meditec Pathology Imaging Systems Product Portfolio
  114. 7.19.5 Carl Zeiss Meditec Recent Developments
  115. 7.20 3D-Histech
  116. 7.20.1 3D-Histech Company Information
  117. 7.20.2 3D-Histech Business Overview
  118. 7.20.3 3D-Histech Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
  119. 7.20.4 3D-Histech Pathology Imaging Systems Product Portfolio
  120. 7.20.5 3D-Histech Recent Developments
8 North America
  1. 8.1 North America Pathology Imaging Systems Revenue (2021-2032)
  2. 8.2 North America Pathology Imaging Systems Revenue by Type (2021-2032)
  3. 8.2.1 North America Pathology Imaging Systems Revenue by Type (2021-2026)
  4. 8.2.2 North America Pathology Imaging Systems Revenue by Type (2027-2032)
  5. 8.3 North America Pathology Imaging Systems Revenue Share by Type (2021-2032)
  6. 8.4 North America Pathology Imaging Systems Revenue by Application (2021-2032)
  7. 8.4.1 North America Pathology Imaging Systems Revenue by Application (2021-2026)
  8. 8.4.2 North America Pathology Imaging Systems Revenue by Application (2027-2032)
  9. 8.5 North America Pathology Imaging Systems Revenue Share by Application (2021-2032)
  10. 8.6 North America Pathology Imaging Systems Revenue by Country
  11. 8.6.1 North America Pathology Imaging Systems Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pathology Imaging Systems Revenue by Country (2021-2026)
  13. 8.6.3 North America Pathology Imaging Systems Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Pathology Imaging Systems Revenue (2021-2032)
  2. 9.2 Europe Pathology Imaging Systems Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pathology Imaging Systems Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pathology Imaging Systems Revenue by Type (2027-2032)
  5. 9.3 Europe Pathology Imaging Systems Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pathology Imaging Systems Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pathology Imaging Systems Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pathology Imaging Systems Revenue by Application (2027-2032)
  9. 9.5 Europe Pathology Imaging Systems Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pathology Imaging Systems Revenue by Country
  11. 9.6.1 Europe Pathology Imaging Systems Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pathology Imaging Systems Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pathology Imaging Systems Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Pathology Imaging Systems Revenue (2021-2032)
  2. 10.2 China Pathology Imaging Systems Revenue by Type (2021-2032)
  3. 10.2.1 China Pathology Imaging Systems Revenue by Type (2021-2026)
  4. 10.2.2 China Pathology Imaging Systems Revenue by Type (2027-2032)
  5. 10.3 China Pathology Imaging Systems Revenue Share by Type (2021-2032)
  6. 10.4 China Pathology Imaging Systems Revenue by Application (2021-2032)
  7. 10.4.1 China Pathology Imaging Systems Revenue by Application (2021-2026)
  8. 10.4.2 China Pathology Imaging Systems Revenue by Application (2027-2032)
  9. 10.5 China Pathology Imaging Systems Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pathology Imaging Systems Revenue (2021-2032)
  2. 11.2 Asia Pathology Imaging Systems Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pathology Imaging Systems Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pathology Imaging Systems Revenue by Type (2027-2032)
  5. 11.3 Asia Pathology Imaging Systems Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pathology Imaging Systems Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pathology Imaging Systems Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pathology Imaging Systems Revenue by Application (2027-2032)
  9. 11.5 Asia Pathology Imaging Systems Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pathology Imaging Systems Revenue by Country
  11. 11.6.1 Asia Pathology Imaging Systems Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pathology Imaging Systems Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pathology Imaging Systems Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pathology Imaging Systems Revenue (2021-2032)
  2. 12.2 SAMEA Pathology Imaging Systems Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pathology Imaging Systems Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pathology Imaging Systems Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pathology Imaging Systems Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pathology Imaging Systems Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pathology Imaging Systems Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pathology Imaging Systems Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pathology Imaging Systems Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pathology Imaging Systems Revenue by Country
  11. 12.6.1 SAMEA Pathology Imaging Systems Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pathology Imaging Systems Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pathology Imaging Systems Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.